Abstracts tagged "Quality Indicators and SLE"

Abstract Number: 1234 • 2016 ACR/ARHP Annual Meeting
Does SLE Care in a Lupus Clinic Result in Higher Quality Scores Than in General Rheumatology Clinics?
Shilpa Arora¹, Ailda Nika¹, Joel Block², Winston Sequeira¹, Jinoos Yazdany³, Laura Trupin³ and Meenakshi Jolly¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Section of Rheumatology, Rush University Medical Center, Chicago, IL, ³Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA
Background/Purpose: We compared the quality of care received by SLE patients at two settings within the same academic institution (lupus clinic or general rheumatology clinic)…
Abstract Number: 1265 • 2013 ACR/ARHP Annual Meeting
Initial Benchmarking Of The Quality Of Medical Care Of Children and Adolescents With Lupus
Ahmad I. Zaal¹, Julia G. Harris², Clovis A. Silva³, Marco F. Sliva⁴, Jiha Lee⁵, Alexandria J. Greenler⁶, Simone Appenzeller⁷, Maraisa Centeville⁷, HaiMei Liu⁸, Joshua D. Pendl⁵, Jennifer L. Huggins¹, Jessica M. Sage⁶ and Hermine Brunner⁹, ¹Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ²Children's Hospital of Wisconsin, Milwaukee, WI, ³Children's Institute, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, ⁴Pediatric Rheumatology Unit-Children’s Institute,, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, ⁵Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁶Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁷Medicine, Faculty of Medical Science, State University of Campinas Unicamp, São Paulo, Brazil, ⁸Children's Hospital of Fundan University, Shanghai, China, ⁹Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Background/Purpose: Recently, 26 quality indicators (QI) for childhood-onset systemic lupus erythematous (cSLE) have been developed based on international consensus and scientific evidence. QI are defined…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].